Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years

Condition:   Chikungunya Virus Interventions:   Biological: CHIKV VLP/adjuvant;   Biological: Placebo Sponsors:   Emergent BioSolutions;   Catalyst Clinical Research Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials